- Rodríguez‐Soto, Ana E;
- Andreassen, Maren M Sjaastad;
- Fang, Lauren K;
- Conlin, Christopher C;
- Park, Helen H;
- Ahn, Grace S;
- Bartsch, Hauke;
- Kuperman, Joshua;
- Vidić, Igor;
- Ojeda‐Fournier, Haydee;
- Wallace, Anne M;
- Hahn, Michael;
- Seibert, Tyler M;
- Jerome, Neil Peter;
- Østlie, Agnes;
- Bathen, Tone Frost;
- Goa, Pål Erik;
- Rakow‐Penner, Rebecca;
- Dale, Anders M
Purpose
Restriction spectrum imaging (RSI) decomposes the diffusion-weighted MRI signal into separate components of known apparent diffusion coefficients (ADCs). The number of diffusion components and optimal ADCs for RSI are organ-specific and determined empirically. The purpose of this work was to determine the RSI model for breast tissues.Methods
The diffusion-weighted MRI signal was described using a linear combination of multiple exponential components. A set of ADC values was estimated to fit voxels in cancer and control ROIs. Later, the signal contributions of each diffusion component were estimated using these fixed ADC values. Relative-fitting residuals and Bayesian information criterion were assessed. Contrast-to-noise ratio between cancer and fibroglandular tissue in RSI-derived signal contribution maps was compared to DCE imaging.Results
A total of 74 women with breast cancer were scanned at 3.0 Tesla MRI. The fitting residuals of conventional ADC and Bayesian information criterion suggest that a 3-component model improves the characterization of the diffusion signal over a biexponential model. Estimated ADCs of triexponential model were D1,3 = 0, D2,3 = 1.5 × 10-3 , and D3,3 = 10.8 × 10-3 mm2 /s. The RSI-derived signal contributions of the slower diffusion components were larger in tumors than in fibroglandular tissues. Further, the contrast-to-noise and specificity at 80% sensitivity of DCE and a subset of RSI-derived maps were equivalent.Conclusion
Breast diffusion-weighted MRI signal was best described using a triexponential model. Tumor conspicuity in breast RSI model is comparable to that of DCE without the use of exogenous contrast. These data may be used as differential features between healthy and malignant breast tissues.